JP2021523895A5 - - Google Patents
Info
- Publication number
- JP2021523895A5 JP2021523895A5 JP2020562128A JP2020562128A JP2021523895A5 JP 2021523895 A5 JP2021523895 A5 JP 2021523895A5 JP 2020562128 A JP2020562128 A JP 2020562128A JP 2020562128 A JP2020562128 A JP 2020562128A JP 2021523895 A5 JP2021523895 A5 JP 2021523895A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- bacterial strain
- sequence
- cancer
- Prior art date
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18171893 | 2018-05-11 | ||
| EP18171893.3 | 2018-05-11 | ||
| EP18178136 | 2018-06-15 | ||
| EP18178136.0 | 2018-06-15 | ||
| GB1810386.1 | 2018-06-25 | ||
| GBGB1810386.1A GB201810386D0 (en) | 2018-06-25 | 2018-06-25 | Compositions comprising bacterial strains |
| GBGB1813460.1A GB201813460D0 (en) | 2018-08-17 | 2018-08-17 | Compositions comprising bacterial strains |
| GB1813460.1 | 2018-08-17 | ||
| GBGB1817642.0A GB201817642D0 (en) | 2018-10-29 | 2018-10-29 | Compositions comprising bacterial strains |
| GB1817642.0 | 2018-10-29 | ||
| GB1820256.4 | 2018-12-12 | ||
| GBGB1820256.4A GB201820256D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
| GBGB1820264.8A GB201820264D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
| GB1820264.8 | 2018-12-12 | ||
| PCT/EP2019/062236 WO2019215345A1 (en) | 2018-05-11 | 2019-05-13 | Compositions comprising bacterial strains |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523895A JP2021523895A (ja) | 2021-09-09 |
| JPWO2019215345A5 JPWO2019215345A5 (https=) | 2022-05-20 |
| JP2021523895A5 true JP2021523895A5 (https=) | 2022-05-20 |
Family
ID=66597549
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562128A Pending JP2021523895A (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2020545563A Expired - Fee Related JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2022062741A Pending JP2022088631A (ja) | 2018-05-11 | 2022-04-05 | 細菌株を含む組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545563A Expired - Fee Related JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2022062741A Pending JP2022088631A (ja) | 2018-05-11 | 2022-04-05 | 細菌株を含む組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US11419902B2 (https=) |
| EP (4) | EP4066845A1 (https=) |
| JP (3) | JP2021523895A (https=) |
| KR (2) | KR20210008393A (https=) |
| CN (2) | CN112601534A (https=) |
| AU (3) | AU2019267170A1 (https=) |
| BR (1) | BR112020022833A2 (https=) |
| CA (2) | CA3099209A1 (https=) |
| CY (1) | CY1125211T1 (https=) |
| DK (1) | DK3743086T3 (https=) |
| ES (1) | ES2916601T3 (https=) |
| HR (1) | HRP20220578T1 (https=) |
| IL (1) | IL278471B2 (https=) |
| LT (1) | LT3743086T (https=) |
| MD (1) | MD3743086T2 (https=) |
| MX (1) | MX2020012061A (https=) |
| PL (1) | PL3743086T3 (https=) |
| RS (1) | RS63273B1 (https=) |
| SG (2) | SG11202011031UA (https=) |
| SI (1) | SI3743086T1 (https=) |
| SM (1) | SMT202200217T1 (https=) |
| TW (2) | TW202014513A (https=) |
| WO (2) | WO2019215346A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA47439A (fr) | 2017-01-31 | 2019-12-11 | Univ Kansas State | Cellules microbiennes, leurs procédés de production, et leurs utilisations |
| TWI812624B (zh) | 2017-06-14 | 2023-08-21 | 南韓商希杰生物科技股份有限公司 | 包含細菌品系之組成物 |
| WO2019079764A1 (en) | 2017-10-20 | 2019-04-25 | Ms Biotech, Inc. | METHODS FOR PRODUCING PLANT MATERIALS EMITTED WITH MEGASPHAERA ELSDENII |
| SG11202011031UA (en) * | 2018-05-11 | 2020-12-30 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| TW202038977A (zh) * | 2018-12-12 | 2020-11-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組成物 |
| WO2020120714A1 (en) * | 2018-12-12 | 2020-06-18 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
| CN112980878B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac8基因敲除的bhk-21细胞系及其构建方法和应用 |
| CN112877275B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac2基因敲除的bhk-21细胞系及其构建方法和应用 |
| WO2023208225A1 (zh) | 2022-04-28 | 2023-11-02 | 慕恩（广州）生物科技有限公司 | 药物组合物、巨球型菌及其应用 |
| WO2023208223A1 (zh) | 2022-04-28 | 2023-11-02 | 慕恩（广州）生物科技有限公司 | 药物组合物、巨球型菌及其应用 |
| KR102551061B1 (ko) * | 2022-05-26 | 2023-07-03 | 중앙대학교 산학협력단 | Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물 |
| CN117018036B (zh) * | 2023-07-28 | 2025-09-05 | 深圳未知君生物科技有限公司 | 巨球形菌属细菌在制备治疗癌症的药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5557520A (en) * | 1978-10-26 | 1980-04-28 | Nisshin Flour Milling Co Ltd | Preparation of carcinostatic substance |
| WO2002080947A1 (fr) | 2001-04-06 | 2002-10-17 | Kyodoken Institute For Animal Science Research & Development | Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| US20040005304A1 (en) | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| GB0307026D0 (en) * | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
| CA2535889A1 (en) | 2003-08-29 | 2005-03-17 | Aton Pharma, Inc. | Combination methods of treating cancer |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| CA3212215A1 (en) | 2012-11-23 | 2014-05-30 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| HK1218560A1 (zh) | 2013-02-04 | 2017-02-24 | Seres Therapeutics, Inc. | 组成与方法 |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| EP3021853A1 (en) * | 2013-07-18 | 2016-05-25 | Baylor College Of Medicine | Method of enhancing potency of immune cells |
| CN104415060A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
| US10203329B2 (en) * | 2013-09-12 | 2019-02-12 | The Johns Hopkins University | Biofilm formation to define risk for colon cancer |
| EP3074027B1 (en) | 2013-11-25 | 2024-12-18 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| US9650654B2 (en) * | 2014-06-25 | 2017-05-16 | William Marsh Rice University | Making C4+ products in bacteria |
| US10366793B2 (en) * | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
| WO2016073381A1 (en) * | 2014-11-03 | 2016-05-12 | Cerus Corporation | Compositions and methods for improved car-t cell therapies |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| CN107405321A (zh) * | 2015-01-23 | 2017-11-28 | 坦普尔大学 | 短链脂肪酸在癌症预防中的应用 |
| US20180078587A1 (en) | 2015-03-18 | 2018-03-22 | Trustees Of Tufts College | Compositions and methods for preventing colorectal cancer |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| HK1254843B (zh) * | 2015-11-20 | 2020-04-17 | 希杰生物科技株式会社 | 包含细菌菌株的组合物 |
| US20190247447A1 (en) * | 2015-11-24 | 2019-08-15 | Seres Therapeutics, Inc. | Designed bacterial compositions |
| WO2017122197A1 (en) * | 2016-01-11 | 2017-07-20 | 3Plw Ltd. | Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes |
| CN107028985A (zh) * | 2016-02-04 | 2017-08-11 | 深圳华大基因研究院 | 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用 |
| US20190125808A1 (en) * | 2016-03-30 | 2019-05-02 | The Trustees Of Columbia University In The City Of New York | Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria |
| US9999641B2 (en) * | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| JP7542946B2 (ja) * | 2016-09-27 | 2024-09-02 | ボード オブ リージェンツ， ザ ユニヴァーシティー オブ テキサス システム | マイクロバイオームをモジュレートすることにより、免疫チェックポイント遮断療法を増強するための方法 |
| US11571446B2 (en) | 2016-11-18 | 2023-02-07 | Sanford Bumham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
| US20190314427A1 (en) | 2016-12-16 | 2019-10-17 | Evelo Biosciences, Inc. | Methods of treating cancer using parabacteroides |
| WO2018112365A2 (en) | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii |
| PL3600363T3 (pl) * | 2017-06-14 | 2021-06-14 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
| TWI812624B (zh) * | 2017-06-14 | 2023-08-21 | 南韓商希杰生物科技股份有限公司 | 包含細菌品系之組成物 |
| SG11202011031UA (en) * | 2018-05-11 | 2020-12-30 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| WO2020120714A1 (en) * | 2018-12-12 | 2020-06-18 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| TW202038977A (zh) * | 2018-12-12 | 2020-11-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組成物 |
-
2019
- 2019-05-13 SG SG11202011031UA patent/SG11202011031UA/en unknown
- 2019-05-13 CA CA3099209A patent/CA3099209A1/en active Pending
- 2019-05-13 CA CA3098971A patent/CA3098971A1/en active Pending
- 2019-05-13 BR BR112020022833-8A patent/BR112020022833A2/pt not_active IP Right Cessation
- 2019-05-13 JP JP2020562128A patent/JP2021523895A/ja active Pending
- 2019-05-13 JP JP2020545563A patent/JP7058449B2/ja not_active Expired - Fee Related
- 2019-05-13 MX MX2020012061A patent/MX2020012061A/es unknown
- 2019-05-13 EP EP22162425.7A patent/EP4066845A1/en active Pending
- 2019-05-13 ES ES19725068T patent/ES2916601T3/es active Active
- 2019-05-13 KR KR1020207035244A patent/KR20210008393A/ko not_active Ceased
- 2019-05-13 TW TW108116449A patent/TW202014513A/zh unknown
- 2019-05-13 SG SG11202011028SA patent/SG11202011028SA/en unknown
- 2019-05-13 CN CN201980031147.8A patent/CN112601534A/zh active Pending
- 2019-05-13 KR KR1020207035242A patent/KR20210008391A/ko not_active Ceased
- 2019-05-13 CN CN201980031512.5A patent/CN112512539A/zh active Pending
- 2019-05-13 PL PL19725068T patent/PL3743086T3/pl unknown
- 2019-05-13 WO PCT/EP2019/062238 patent/WO2019215346A1/en not_active Ceased
- 2019-05-13 AU AU2019267170A patent/AU2019267170A1/en not_active Abandoned
- 2019-05-13 AU AU2019267171A patent/AU2019267171A1/en not_active Abandoned
- 2019-05-13 DK DK19725068.1T patent/DK3743086T3/da active
- 2019-05-13 RS RS20220465A patent/RS63273B1/sr unknown
- 2019-05-13 LT LTEPPCT/EP2019/062238T patent/LT3743086T/lt unknown
- 2019-05-13 WO PCT/EP2019/062236 patent/WO2019215345A1/en not_active Ceased
- 2019-05-13 EP EP19725067.3A patent/EP3790564A1/en not_active Withdrawn
- 2019-05-13 TW TW108116469A patent/TW202011975A/zh unknown
- 2019-05-13 SM SM20220217T patent/SMT202200217T1/it unknown
- 2019-05-13 EP EP19725068.1A patent/EP3743086B1/en active Active
- 2019-05-13 SI SI201930216T patent/SI3743086T1/sl unknown
- 2019-05-13 EP EP22162255.8A patent/EP4056192A1/en active Pending
- 2019-05-13 HR HRP20220578TT patent/HRP20220578T1/hr unknown
- 2019-05-13 MD MDE20201221T patent/MD3743086T2/ro not_active IP Right Cessation
-
2020
- 2020-09-04 US US17/013,026 patent/US11419902B2/en active Active
- 2020-11-03 IL IL278471A patent/IL278471B2/en unknown
- 2020-11-11 US US17/095,427 patent/US20210275605A1/en not_active Abandoned
-
2022
- 2022-04-05 JP JP2022062741A patent/JP2022088631A/ja active Pending
- 2022-05-27 CY CY20221100367T patent/CY1125211T1/el unknown
- 2022-06-23 US US17/847,336 patent/US20230158083A1/en not_active Abandoned
-
2023
- 2023-02-03 AU AU2023200562A patent/AU2023200562A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523895A5 (https=) | ||
| JP2018199695A5 (https=) | ||
| Chua et al. | Designer probiotics for the prevention and treatment of human diseases | |
| JP2022088631A5 (https=) | ||
| JP2019001815A5 (https=) | ||
| RU2020132171A (ru) | Новая бифидобактерия, характеризующаяся различными функциями, и ее применение | |
| HRP20220578T1 (hr) | Pripravci koji sadrže bakterijske sojeve | |
| Mirza et al. | Efficacy of Bacillus clausii UBBC-07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy | |
| Corr et al. | Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens | |
| JPWO2019215345A5 (https=) | ||
| Hu et al. | Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice | |
| JP2019522649A5 (https=) | ||
| JP2019517828A5 (https=) | ||
| Abedin-Do et al. | Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells | |
| Panebianco et al. | Microbiota manipulation by probiotics administration as emerging tool in cancer prevention and therapy | |
| JP2022540186A (ja) | ビフィドバクテリウム・ビフィダム菌株、その組成物及び関連用途 | |
| JP2015213501A5 (https=) | ||
| Sharma et al. | Role of probiotics in the management of lung cancer and related diseases: An update | |
| US10660923B2 (en) | Sinusitis diagnostics and treatments | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| Chen et al. | Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases | |
| Ashique et al. | It is all about probiotics to control cervical cancer | |
| CA2409813C (en) | Compositions and methods for treatment of mucosal infections | |
| Mandal et al. | Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics | |
| Sharma | Importance of probiotics in cancer prevention and treatment |